FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely cardiology and concerns treating the patients with ST segment elevation acute myocardial infarction. That is ensured by the two-bolus intravenous administration of the thrombolytic preparation Fortelysine in a dose of 10 mg, and 30 minutes later in a dose of 5 mg.
EFFECT: presented mode of administration of Fortelysine provides the effective recovery of the antegrade coronary blood flow in the infarction-involved coronary artery in the patients with ST segment elevation acute myocardial infarction.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH STAGING OF ST SEGMENT COMPLICATED BY CARDIOGENIC SHOCK | 2017 |
|
RU2649760C1 |
| METHOD FOR TREATMENT OF ISCHEMIC STROKE | 2018 |
|
RU2670203C1 |
| METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS | 2002 |
|
RU2226097C2 |
| METHOD FOR PREDICTING COMPLICATIONS IN CASE OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197173C2 |
| METHOD FOR ENDOVASCULAR CORRECTION OF NO-REFLOW PHENOMENON IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION OF CULPRIT ARTERY | 2014 |
|
RU2574123C1 |
| METHOD OF EVALUATING EFFICIENCY OF THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2008 |
|
RU2391904C2 |
| METHOD OF RE-PERFUSION THERAPY IN ACUTE MYOCARDIAL INFARCTION WITH ELEVATED ST | 2006 |
|
RU2324497C2 |
| METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
| METHOD FOR CARE OF PATIENTS WITH ACUTE CORONARY SYNDROME UNDER CONDITIONS OF MEDICAL INSTITUTION WITH SPECIALIZED DEPARTMENT OF PERCUTANEOUS CORONARY INTERVENTIONS | 2015 |
|
RU2641851C2 |
| METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
